Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolios
Close

Sumitomo Dainippon Pharma Co Ltd (4506)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
355.0 -21.0    -5.59%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3495000006 
  • Volume: 6,478,300
  • Bid/Ask: 356.0 / 357.0
  • Day's Range: 343.0 - 373.0
Sumitomo Dainippon Pharma 355.0 -21.0 -5.59%

4506 Balance Sheet

 
Featured here, the Balance Sheet for Sumitomo Dainippon Pharma Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets - 264167 292746 320798
Cash and Short Term Investments - 36457 60397 100737
Cash - - - -
Cash & Equivalents - 36457 60397 94475
Short Term Investments - - - 6262
Total Receivables, Net - 97306 96887 98670
Accounts Receivables - Trade, Net - 94465 93892 95774
Total Inventory - 104769 107610 101482
Prepaid Expenses - - - -
Other Current Assets, Total - 25635 27852 19909
Total Assets - 1059970 1148855 1140702
Property/Plant/Equipment, Total - Net - 59019 60202 60050
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - 222415 234568 227371
Intangibles, Net - 332372 356580 350985
Long Term Investments - - - 170598
Note Receivable - Long Term - 2841 2995 2896
Other Long Term Assets, Total - 173195 195306 170598
Other Assets, Total - 41900 48028 39883
Total Current Liabilities - 421155 370747 363618
Accounts Payable - 50385 57712 46329
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - 227588 - 127617
Current Port. of LT Debt/Capital Leases - 227588 139588 127617
Other Current liabilities, Total - 143182 173447 189672
Total Liabilities - 716377 736810 723679
Total Long Term Debt - 184254 244212 244170
Long Term Debt - 184254 244212 244170
Capital Lease Obligations - - - -
Deferred Income Tax - 48832 56808 49129
Minority Interest - 42 38 36
Other Liabilities, Total - -380970 65005 -276367
Total Equity - 343593 412045 417023
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - 22400 22400 22400
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - 171708 217421 246293
Treasury Stock - Common - -682 -682 -682
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - 150167 172906 149012
Total Liabilities & Shareholders' Equity - 1059970 1148855 1140702
Total Common Shares Outstanding 397.29 397.29 397.29 397.29
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4506 Comments

Write your thoughts about Sumitomo Dainippon Pharma Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email